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Madagascar is a geographically isolated country considered a biodiversity hotspot with unique genomics. Both the low-income and
the geographical isolation represent risk factors for the development of diabetes. During a humanitarian health campaign
conducted in Ambanja, a rural city in the northern part of Madagascar, we identified 42 adult subjects with diabetes and
compared their features to 24 randomly enrolled healthy controls. 42.9% (n = 18) of diabetic subjects showed HbA1c
values≥ 9.0%. Unexpectedly, waist circumference and BMI were similar in people with diabetes and controls. Different from the
healthy controls, diabetic subjects showed a low prevalence of obesity (5.7% versus 30%, p = 0 02). Accordingly, we found a high
prevalence of autoimmune diabetes as 12% of people with diabetes showed positivity for the autoantibody against
glutamic acid decarboxylase. Diabetic subjects with positive autoantibody had higher HbA1c values (11.3± 4.1% versus
8.3± 2.6%, p = 0 03) compared to diabetic subjects with negative autoantibody. In conclusion, here we describe the presence of
diabetes and its features in a rural area of Northern Madagascar, documenting poor glycaemic control and a high prevalence of
autoimmune diabetes. These data highlight that the diabetes epidemic involves every corner of the world possibly with different
patterns and features.
1. Introduction
The global prevalence of type 2 diabetes is continuously
increasing, and evidences show that it is no more solely
a disease of affluence. Indeed, there is a call to address dia-
betes in the world’s poorest people, where it can develop
in atypical forms [1]. Moreover, the International Diabetes
Federation (IDF) estimates that 80% of people with diabe-
tes live in low- and middle-income countries. Nevertheless,
in these countries, diabetes has been neglected for years
and in most cases it is still undiagnosed. Data published
in the 7th edition of the IDF Atlas show that 66.7% of
people with diabetes living in Africa are undiagnosed [2]
and thus untreated, raising concerns about the impact of
diabetes and diabetes-related complications on the mor-
bidity and mortality of African people. In this regard, we
have previously shown a rising prevalence of cardiovascu-
lar complications of diabetes in rural areas of sub-Saharan
Africa, highlighting the problem of cardiometabolic dis-
eases also in the African continent [3]. Madagascar is a
geographically isolated country off the southern coast of
Africa, mostly medically underserved, and little is known
about diabetes and its complications in this country.
Because of its geographical isolation, Madagascar is
considered a biodiversity hotspot with unique genomics.
Both the low-income and the geographical isolation repre-
sent risk factors for the development of diabetes. In this
study, we aimed to describe clinical and pathological
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features of diabetes mellitus in Malagasy people of
Ambanja, a rural city in the northern part of Madagascar.
2. Methods
A clinical health campaign was conducted at the “St.
Damien” Hospital in Ambanja in October 2013. 650 volun-
tary outpatients were tested for blood glucose to identify
subjects with unknown diabetes mellitus. Diabetes mellitus
was diagnosed according to ADA diagnostic criteria (at least
two fasting glycaemia> 126mg/dl or one random glycae-
mia> 200mg/dl with symptoms of diabetes) [4]; subjects
with fasting blood glucose between 110mg/dl and 126mg/dl
underwent an Oral Glucose Tolerance Test (OGTT), and
diagnosis of diabetes mellitus was made if blood glucose
120 minutes after the ingestion of 75 grams of glucose
was >200mg/dl.
All subjects found to be affected by diabetes were
enrolled. Moreover, nondiabetic subjects were recruited at
the rate of 1 control each 2 diabetic subjects (1 : 2) as controls.
An additional 15% of control subjects were recruited to
increase the sample size of the study. A blood sample was
drawn from all enrolled subjects in order to measure HbA1c
(HPLC liquid chromatography). Autoantibodies against
glutamic acid decarboxylase (GADA) were measured by a
radioimmunoprecipitation assay [5] utilizing a human
recombinant full-length GAD65 cDNA provided by Dr Å.
Lernmark (Lund University, Malmö, Sweden). The GAD
cDNA was transcribed in vitro and translated in the presence
of [35S]-methionine (Perkin-Elmer Italia, Monza, Italy)
using the Sp6 TNT-coupled rabbit reticulocyte system
(Promega Italia, Milan, Italy). A GADA index of 0.019 was
used as a limit of positivity of the assay. It was calculated
according to the 99th percentile of 200 healthy controls
(GADA index= sample cpm−negative standard control
cpm/positive standard control cpm−negative standard
control cpm). In Diabetes Autoantibody Standardization
Program (DASP IDS/CDC), the GADA assay obtained 97%
specificity and 88% sensitivity. GADA were measured only
in samples from subjects with diabetes. C-peptide was
measured in sera from subjects with diabetes by sandwich
chemiluminescent immunoassay (LIAISON, DiaSorin,
Saluggia, VC, Italy).
A complete physical examination was performed: weight
was recorded to the nearest 0.1 kg; height was measured with
a stadiometer and recorded to the nearest 0.5 cm; body mass
index (BMI) as the ratio between weight in kg and the
squared height in meters; waist circumference was measured
using a metric nonstretching measuring tape, midway
between the inferior margin of the lowest rib and the iliac
crest in the horizontal plane at the end of normal expiration
and recorded to the nearest 1.0 cm; blood pressure (systolic
and diastolic) was measured by trained doctors while patients
were sitting.
Values are expressed as mean± standard deviation
(SD) for continuous variables and as proportions for
categorical variables (%). The Shapiro-Wilk normality test
was used to assess the normality of continuous variable
distributions (variables with the Shapiro-Wilk statistic< 0.9,
p values< 0.05 were considered nonnormally distributed).
Comparisons between groups were done using Student’s
t-test, Kruskal-Wallis, chi-square, or Fisher’s exact test
depending on distribution. A two-tailed p value< 0.05
was considered statistically significant. All statistical analy-
ses were performed using SPSS 21.0 for Windows.
The study was performed in accordance with the Decla-
ration of Helsinki, and the protocol was approved by the
ethic committee of the University Campus Bio-Medico of
Rome.
3. Results
Forty-two subjects were affected by diabetes and showed
higher fasting glycaemia and HbA1c than controls (n = 24);
no significant differences were found between diabetics and
controls in terms of alcohol consumption, smoking status,
and family history of diabetes or obesity. Surprisingly, no sig-
nificant differences were found in body mass index (BMI),
waist circumference, and blood pressure between the two
groups (Table 1). The distribution of BMI categories (under-
weight, normal weight, overweight, and obese) showed an
unusual pattern, with more underweight-normal weight sub-
jects than overweight-obese subjects (68.6% versus 51.4%).
Moreover, the proportion of obese subjects among
healthy individuals was significantly higher than that
observed among diabetic subjects (25.0% versus 4.8%,
p = 0 02) (Figure 1).
42.9% (n = 18) of subjects with diabetes showed HbA1c
values≥ 9.0%, while just 31.0% (n = 13) showed an adequate
metabolic control, with a HbA1c value< 7.0%. Mean C-
peptide levels were 2.1± 1.9 ng/ml. C-peptide levels showed
a positive association with BMI (r = 0 41, p < 0 01).
A high prevalence of GADA positivity was found (12%)
among people affected by diabetes. GADA-positive subjects
had significantly higher HbA1c values (11.3%± 4.1% versus
8.3%± 2.6%, p = 0 01). Accordingly, GADA-positive subjects
showed a trend towards higher levels of fasting glycaemia
(298.0± 99.2 versus 208.8± 117.6, p = 0 06) than GADA-
negative subjects (Table 2).
4. Discussion
In this report from a humanitarian health campaign we doc-
umented the presence of diabetes and its features in a rural
area of the northern Madagascar, filling a hole in our knowl-
edge of diabetes in southern Africa. IDF recently stated the
number of data sources examining diabetes in adults in the
Africa region is still very low, but no data were reported spe-
cifically for Madagascar. Our data show a poor level of met-
abolic control and widespread ignorance of the disease, and
confirm that diabetes is a health emergency which involves
also the underserved countries which are rapidly experienc-
ing an uncontrolled westernization of diet and habits. This
could have a tremendous impact in geographical regions with
different and unknown genetic backgrounds, such as African
countries in general and Madagascar in particular. Different
populations could present different types of diabetes, with
varying severity of insulin deficiency and/or resistance, and
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this has implications for clinical features, management and
outcomes [6]. Indeed, Malagasy people living in the neigh-
bourhood of Ambanja show different features from classical
type 2 diabetes (T2D), as for waist circumference and BMI
that are comparable to the healthy controls. Since we have
confirmed also in this population that higher BMI is associ-
ated to higher levels of serum C-peptide, this suggests that
diabetic people from Ambanja may have lower levels of
insulin resistance. Moreover, more diabetics were under-
weight or of normal weight than overweight/obese, confirm-
ing previous observations in other low-income populations
[6]. The clinical features we found could be in part be
explained by our findings of a high prevalence of GADA
positivity, 12% compared to those described in other coun-
tries [7–9]. Indeed, GADA-positive adults with diabetes have
been shown to have lower BMI than GADA-negative subjects
in previous reports [7, 9, 10]. Accordingly, we found a trend
towards lower BMI in GADA-positive subjects, even though
the low power of the analysis due to the low sample size is
probably affecting the statistical significance. Other factors
such as malnutrition and genetic background may also have
an important role in this population in determining the clin-
ical features of diabetes, and further studies in this regard are
needed. Diabetes mellitus is a heterogeneous syndrome
where genetic predisposition plays an important role in both
T2D and autoimmune. In particular, prevalence of autoim-
mune diabetes appears to be very high in geographically
isolated countries like Sardinia [11, 12]. Madagascar is a
low-income island country in the Indian Ocean, off the
southern coast of Africa. Malagasy is a unique population
with different genetic background and peculiar food habits
for an African population. While the poverty of urban areas
increases the risk of type 2 diabetes, geographical isolation
may predispose to an increased risk of autoimmune diabetes,
in part explaining the high prevalence of adult autoimmune
diabetes we found. As already shown in other ethnic groups
[9, 10], Malagasy adults with autoimmune diabetes showed
higher fasting glycaemia and HbA1c values than Ab-
negative subjects. The poorer metabolic control of subjects
affected by autoimmune diabetes, together with the high
prevalence we described, is an alarming finding of this study,
calling for urgent actions to address diabetes in this region.
We acknowledge this study has several limitations. As
first, we are reporting results from a small sample size, but
the study is still of value because of the geographical area
where they were collected. Indeed, to the best of our knowl-
edge, no diabetes registries were available for this area to
describe diabetes in a larger cohort. Thus, we had to rely only
on data collected during our humanitarian mission from
people identified as being affected by diabetes. As well,
p = 0.02



































Figure 1: Distribution of BMI categories among diabetes and
control subjects. The prevalence of obesity was significantly higher
in controls compared to subjects with diabetes.
Table 1: Population features.
Diabetes (n = 42) Nondiabetes (n = 24) p
Age, years (mean± SD) 57.4± 11.8 62.4± 13.9 0.13
Sex
0.14M, n (%) 20 (47.6) 7 (29.2)
F, n (%) 22 (52.4) 17 (70.8)
BMI, kg/m2 (mean± SD) 23.4± 4.6 25.1± 5.3 0.16
Waist circumference, cm (mean± SD) 83.4± 14.9 84.4± 12.0 0.79
Blood pressure
Systolic, mmHg (mean± SD) 144.5± 31.0 142.7± 27.0 0.81
Diastolic, mmHg (mean± SD) 90.6± 14.8 89.5± 14.7 0.79
Smoke, n (%) 5 (11.9) 2 (8.3) 0.50
Alcohol, n (%) 6 (14.3) 3 (12.5) 0.58
Family history of DM, n (%) 14 (33.3) 5 (21.7) 0.25
Family history of obesity, n (%) 16 (38.1) 9 (37.5) 0.59
Fasting glycaemia, mg/dl (mean± SD) 219.4± 118.2 104.2± 19.7 <0.01
HbA1c, % (mean± SD) 8.6± 2.9 5.8± 0.7 <0.01
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methods used to screen subjects and the recruitment strategy
may have partially led to a population bias. Therefore, we are
not reporting data about diabetes prevalence overall and we
aimed to characterize only the clinical and the pathophysio-
logic features of diabetes in this region. Moreover, we did
not collect data about education and occupation of the
enrolled subjects, which would have helped in the description
of diabetes in this area. Finally, we did not investigate the
presence of monogenic forms of diabetes. Because of the
above-discussed geographically isolation, monogenic diabe-
tes could also be prevalent in this area and could theoret-
ically account for the unusual pattern of BMI distribution
we found.
Nevertheless, in this study, we describe for the first time
the presence and features of autoimmune diabetes of the
adults in Madagascar and highlight the burden of diabetes
in a corner of the world far away from the lights of medical
research and healthcare systems.
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